Antinuclear Antibodies: Diagnostic Markers for Autoimmune Diseases and Probes for Cell Biology

Advances in Immunology

Volumn 44, Issue C, 1989, Pages 93-151

  Tan, Eng M ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACEBUTOLOL; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; CHLORPROMAZINE; DNA ANTIBODY; EPITOPE; HISTONE; HYDRALAZINE; PROCAINAMIDE; QUINIDINE;

AUTOIMMUNITY; CLONING; CYTOLOGY; DERMATOMYOSITIS; DIAGNOSIS; DRUG INDUCED DISEASE; HUMAN; MIXED CONNECTIVE TISSUE DISEASE; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW; SCLERODERMA; SIDE EFFECT; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; DERMATOMYOSITIS; DIAGNOSIS, DIFFERENTIAL; DNA; HISTONES; HUMAN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIXED CONNECTIVE TISSUE DISEASE; MODELS, BIOLOGICAL; MYOSITIS; RECOMBINANT PROTEINS; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME;

EID: 0024518559     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/S0065-2776(08)60641-0     Document Type: Article

References (232)

1. Tan, E.M., Autoantibodies to nuclear antigens (ANA): Their immunobiology and medicine. Adv. Immunol. 33 (1982), 167–240.
2. Hargraves, M.M., Richmond, H., Morton, R., Presentation of two bone marrow elements: The “tart” cells and the “L.E.” cell. Mayo Clin. Proc. 27 (1948), 25–28.
3. Robbins, W.C., Holman, H.R., Deicher, H., Kunkel, H.G., Complement fixation with cell nuclei and DNA in lupus erythematosus. Proc. Soc. Exp. Biol. Med. 96 (1957), 575–579.
4. Holman, R., Deicher, H.R., The reaction of the lupus erythematosus (L.E.) cell factor with deoxyribonucleoprotein of the cell nucleus. J. Clin. Invest. 38 (1959), 2059–2072.
5. Kunkel, H.G., Holman, H.R., Deicher, H.R.G., Ciba Found. Symp. Cell. Aspects Immun., Basel. “Multiple “Autoantibodies” to cell constituents in systemic lupus erythematosus.”, 1960, 429–437.
6. Tan, E.M., Kunkel, H.G., Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus. J. Immunol. 96 (1966), 464–471.
7. Northway, J.D., Tan, E.M., “Differentiation of antinuclear antibodies giving speckled staining patterns in immunofluorescence.” Clin. Immunol. Immunopathol. I (1972), 140–152.
8. Sharp, G.C., Irwin, W., Tan, E.M., Gould, G., Holman, H.R., Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am. J. Med. 52 (1972), 148–159.
9. Mattioli, M., Reichlin, M., Physical association of two nuclear antigens and mutual occurrence of their antibodies: The relationship of the Sm and RNA protein (Mo) systems in SLE sera. J. Immunol. 110 (1973), 1318–1324.
10. Lerner, M.R., Steitz, J.A., Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. U.S.A. 76 (1979), 5495–5497.
11. Busch, H., Reddy, R., Rothblum, L., Choy, Y., SnRNAs, SnRNPs and RNA processing. Annu. Rev. Biochem. 51 (1982), 617–654.
12. Brunel, C., Sri-Wadada, J., Jeanteur, P., snRNPs and scRNPs in eukaryotic cells. Prog. Mol. Subcell. Biol. 9 (1985), 1–52.
13. Mattioli, M., Reichlin, M., Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Arthritis Rheum. 17 (1974), 421–429.
14. Alspaugh, M.A., Tan, E.M., Antibodies to cellular antigens in Sjögren's syndrome. J. Clin. Invest. 55 (1975), 1067–1073.
15. Lerner, M.R., Boyle, J.A., Hardin, J.A., Steitz, J.A., Two novel classes of small ribonucleoproteins detected by antibodies associated with lupus erythematosus. Science 211 (1981), 400–402.
16. Rinke, J., Steitz, J.A., Precursor molecules of both human 5S ribosomal and transfer RNAs are bound by a cellular protein reactive with anti-La antibodies. Cell 29 (1982), 149–159.
17. Douvas, A.S., Achten, M., Tan, E.M., Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma. J. Biol. Chem. 254 (1979), 10514–10522.
18. Shero, J.H., Bordwell, B., Rothfield, N.F., Earnshaw, W.C., Autoantibodies to topoisomerase I are found in sera from scleroderma patients. Science 231 (1986), 737–740.
19. Maul, G.G., French, B.T., Van Venrooij, W.J., Jimenez, S.A., Topoisomerase I identified by scleroderma 70 antisera: Enrichment of topoisomerase I at the centromere in mouse mitotic cells before anaphase. Proc. Natl. Acad. Sci. U.S.A. 83 (1986), 5145–5149.
20. Guldner, H.H., Szostecki, C., Vosberg, H.P., Lakomek, H.J., Penner, E., Bautz, F.A., Scl-70 autoantibodies from scleroderma patients recognize a 95KD protein identified as DNA topoisomerase I. Chromosoma 94 (1986), 132–138.
21. Miyachi, K., Fritzler, M.J., Tan, E.M., Autoantibody to a nuclear antigen in proliferating cells. J. Immunol. 121 (1978), 2228–2234.
22. Bravo, R., Rainer, F., Blundell, P.A., Macdonald-Bravo, H., Cyclin/PCNA is the auxiliary protein of DNA polymerase delta. Nature (London) 326 (1987), 515–517.
23. Prelich, G., Tan, C.K., Kostura, M., Mathews, M.B., So, A.G., Downey, K.M., Stillman, B., Functional identity of proliferating cell nuclear antigen and a DNA polymerase delta auxiliary protein. Nature (London) 326 (1987), 517–520.
24. Yang, V.W., Lerner, M.R., Steitz, J.A., Flint, S.J., A small nuclear ribonucleoprotein is required for splicing of adenoviral early RNA sequences. Proc. Natl. Acad. Sci. U.S.A. 78 (1981), 1371–1375.
25. Tan, E.M., Carr, R.I., Schur, P.H., Kunkel, H.G., DNA and antibody to DNA in the serum of patients with systemic lupus erythematosus. J. Clin. Invest. 45 (1966), 1732–1740.
26. Stollar, B.D., Antibodies to DNA. CRC Crit. Rev. Biochem. 20 (1986), 1–36.
27. Stollar, B.D., Levine, L., Lehrer, H.I., Van Vunakis, H., The antigenic determinants of denatured DNA reactive with lupus erythematosus serum. Proc. Natl. Acad. Sci. U.S.A. 48 (1962), 874–880.
28. Fritzler, M.J., Tan, E.M., Antibodies to histones in drug-induced and idiopathic lupus erythematosus. J. Clin. Invest. 62 (1978), 560–567.
29. Rubin, R.L., Joslin, F.G., Tan, E.M., Specificity of anti-histone antibodies in systemic lupus erythematosus. Arthritis Rheum. 25 (1982), 779–782.
30. Conner, G.E., Nelson, D., Wiesniewolski, R., Lahita, R.G., Blobel, G., Kunkel, H.G., Protein antigens of the RNA-protein complexes detected by anti-Sm and anti-RNP antibodies found in serum of patients with systemic lupus erythematosus and related disorders. J. Exp. Med. 156 (1982), 1475–1486.
31. Fisher, D.E., Conner, G.E., Reeves, W.H., Blobel, G., Kunkel, H.G., Synthesis and assembly of human small nuclear ribonucleoproteins generated by cell-free translation. Proc. Natl. Acad. Sci. U.S.A. 80 (1983), 6356–6360.
32. Yamagata, H., Harley, J.B., Reichlin, M., Molecular properties of the Ro/SSA antigen and enzyme-linked immunosorbent assay for quantitation of antibody. J. Clin. Invest. 74 (1984), 625–633.
33. Harmon, C.E., Deng, J.-S., Peebles, C.L., Tan, E.M., The importance of tissue substrate in the SS-A/Ro antigen-antibody system. Arthritis Rheum. 27 (1984), 166–173.
34. Lieu, T.-S., Jiang, M., Steigerwald, J.S., Tan, E.M., Identification of the SS-A/Ro intracellular antigen with autoimmune sera. J. Immunol. Methods 71 (1984), 217–228.
35. Reddy, R., Henning, D., Tan, E.M., Busch, H., Identification of a La protein binding site in a RNA polymerase III transcript (4.51 RNA). J. Biol. Chem. 258 (1983), 8352–8356.
36. Francoeur, A.M., Mathews, M.B., Interaction between VA-RNA and the lupus antigen La: Formation of a ribonucleoprotein particle. in vitro. Proc. Natl. Acad. Sci. U.S.A. 79 (1982), 6772–6776.
37. Chan, E.K.L., Francoeur, A.M., Tan, E.M., Epitopes, structural domains and asymmetry of amino acid residues in SS-B/La nuclear protein. J. Immunol. 136 (1986), 3744–3749.
38. Chan, E.K.L., Tan, E.M., The small nuclear ribonucleoprotein SS-B/La binds RNA with a conserved protease-resistant domain of 28 KD Mol. Cell Biol. 7 (1987), 2588–2591.
39. Mimori, T., Akizuki, M., Yamagata, H., Inada, S., Yoshida, S., Homma, M., Characterization of a high molecular weight acidic nuclear protein recognized by autoantibodies in sera from patients with polymyositis-scleroderma overlap. J. Clin. Invest. 68 (1981), 611–620.
40. Francoeur, A.M., Peebles, C.L., Gomper, P.T., Tan, E.M., Identification of Ki (Ku, p70/p80) autoantigens and analysis of anti-Ki autoantibody reactivity. J. Immunol. 136 (1986), 1648–1653.
41. Reeves, W.H., Use of monoclonal antibodies for the characterization of novel DNA-binding proteins recognized by human autoimmune sera. J. Exp. Med. 161 (1985), 18–39.
42. Mimori, T., Hardin, J.A., Mechanisms of interaction between Ku protein and DNA. J. Biol. Chem. 261 (1986), 10375–10379.
43. Takasaki, Y., Deng, J.S., Tan, E.M., A nuclear antigen associated with cell proliferation and blast transformation. Its distribution in synchronized cells. J. Exp. Med. 154 (1981), 1899–1909.
44. Bravo, R., Fey, S.J., Bellatin, J. Jr., Larson, P.M., Arvelo, J., Celis, J.E., Identification of a nuclear and of a cytoplasmic polypeptide whose reactive proportions are sensitive to changes in rate of cell proliferation. Exp. Cell Res. 136 (1981), 311–317.
45. Mathews, M.B., Bernstein, R.M., Franze, B.R., Garrels, J.I., Identity of the proliferating cell nuclear antigen and cyclin. Nature (London) 309 (1984), 374–376.
46. Takasaki, Y., Fishwild, D., Tan, E.M., Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera. J. Exp. Med. 159 (1984), 981–992.
47. Ogata, K., Ogata, Y., Nakamura, R.M., Tan, E.M., Purification and N-terminal amino acid sequence of proliferating cell nuclear antigen (PCNA)/cyclin and development of ELISA for anti-PCNA antibodies. J. Immunol. 135 (1985), 2623–2627.
48. Francoeur, A.M., Peebles, C.L., Heckman, K.J., Lee, J.C., Tan, E.M., Identification of ribosomal protein autoantigens. J. Immunol. 135 (1985), 2378–2384.
49. Elkon, K.B., Parnassa, A.P., Foster, C.L., Lupus autoantibodies target ribosomal P proteins. J. Exp. Med. 162 (1985), 459–471.
50. Eisenberg, R.A., Tan, E.M., Dixon, F.J., Presence of anti-Sm reactivity in autoimmune mouse strains. J. Exp. Med. 147 (1978), 582–587.
51. Eisenberg, R.A., Craven, S.Y., Warren, R.W., Cohen, P.L., Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice. J. Clin. Invest. 80 (1987), 691–697.
52. Notman, D.D., Kurata, N., Tan, E.M., Profiles of antinuclear antibodies in systemic rheumatic diseases. Ann. Intern. Med. 83 (1975), 464–469.
53. Boey, M.L., Peebles, C.L., Tsay, G., Feng, P.H., Tan, E.M. (1988). “Clinical and autoantibody correlations in Orientals with SLE.” Ann. Rheum. Dis. (In press).
54. Theofilopoulos, A.N., Dixon, F.J., Murine models of systemic lupus erythematosus. Adv. Immunol. 37 (1985), 358–369.
55. Pollard, K.M., Jones, J.E., Tan, E.M., Theofilopoulos, A.N., Dixon, F.J., Rubin, R.L., Polynucleotide specificities of murine monoclonal anti DNA antibodies. Clin. Immunol. Immunopathol. 40 (1986), 197–208.
56. Pisetsky, D.S., Caster, S.A., Binding specificity of a monoclonal anti DNA antibody. Mol. Immunol. 19 (1982), 645–650.
57. Andrezejewski, C., Rauch, J., Lafer, E., Stollar, B.D., Schwartz, R.S., Antigen-binding diversity and idiotypic cross-reactions among hybridoma autoantibodies to DNA. J. Immunol. 126 (1981), 226–231.
58. Koffler, D., Schur, P.H., Kunkel, H.G., J. Exp. Med. 126 (1967), 607–624.
59. Swaak, G.A.J., Aarden, L.A., van Epps, L.W.S., Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. Arthritis Rheum. 22 (1979), 226–235.
60. Sano, H., Morimoto, C., Isolation of DNA from DNA/anti-DNA antibody immune complexes in systemic lupus erythematosus. J. Immunol. 126 (1981), 538–561.
61. Ikebe, K., Gupta, C., Tan, E.M., Characterization of DNA in polyethylene glycol precipitated immune complexes from sera of patients with systemic lupus erythematosus. Clin. Exp. Immunol. 53 (1983), 169–177.
62. Burlingame, R.W., Lowe, W.E., Wang, B.C., Moudrianakis, E.N., Crystallographic studies of the octameric histone core of the nucleosome at a resolution of 3.3 angstroms. Science 228 (1985), 546–553.
63. Klug, A., Finch, J.T., Richmond, T.J., Crystallographic structure of the octamer histone core of the nucleosome. Science 229 (1985), 1109–1110.
64. Aitcheson, C.T., Peebles, C., Joslin, F., Tan, E.M., Characteristics of antinuclear antibodies in rheumatoid arthritis. Arthritis Rheum. 23 (1980), 528–538.
65. Rekvig, O.P., Hannestad, K., Human autoantibodies that react with both cell nuclei and plasma membranes display specificity for the octamer of histones H2A, H2B, H3 and H4 in high salt. J. Exp. Med. 152 (1980), 1720–1723.
66. Molden, D.P., Klipple, G.L., Peebles, C.L., Rubin, R.L., Nakamura, R.M., Tan, E.M., IgM anti-histone H3 antibodies associated with undifferentiated rheumatic disease syndromes. Arthritis Rheum. 29 (1986), 39–46.
67. Tan, E.M., An immunologic precipitin system between soluble nucleoprotein and serum antibody in systemic lupus erythematosus. J. Clin. Invest. 46 (1967), 735–745.
68. Lachmann, P.J., A two-stage indirect L.E. cell test. Immunology 4 (1961), 142–149.
69. Godman, G.C., Deitch, A.D., Klemperer, P., The composition of the L.E. and hematocytic bodies of systemic lupus erythematosus. Am. J. Pathol. 34 (1958), 1–11.
70. Rubin, R.L., Waga, S., “Anti-histone antibodies in systemic lupus erythematosus.” J. Rheumatol. 14:Suppl. 13 (1987), 118–126.
71. Thomas, J.O., Wilson, C.M., Hardin, J.A., The major core histone antigenic determints in systemic lupus erythematosus are in the trypsin-sensitive regions. FEBS Lett. 169 (1984), 90–96.
72. Gohill, J., Cary, P.D., Couppez, M., Fritzler, M.J., Antibodies from patients with drug-induced and idiopathic lupus erythematosus react with epitopes restricted to the amino and carboxyl termini of histone. J. Immunol. 135 (1985), 3116–3121.
73. Portanova, J.P., Arndt, R.E., Tan, E.M., Kotzin, B.L., Anti-histone antibodies in idiopathic and drug-induced lupus recognize distinct intrahistone regions. J. Immunol. 138 (1987), 446–451.
74. Padgett, R.A., Mount, S.M., Steitz, J.A., Sharp, P.A., Splicing of messenger RNA precursors is inhibited by antisera to small nuclear ribonucleoprotein. Cell 35 (1983), 101–107.
75. Bozzoni, I., Amaldi, F., Anneis, F., Beccari, E., Fragapare, P., Pierandrei-Amaldi, P., Splicing of Xenopus laevis ribosomal protein RNAs is inhibited in vivo by antisera to snRNP. J. Mol. Biol. 180 (1984), 1173–1178.
76. Sharp, P.A., Splicing of messenger RNA precursors. Science 235 (1987), 766–771.
77. Van Venrooij, W.J., “Autoantibodies against small nuclear ribonucleoprotein components.” J. Rheumatol. 14:Suppl. 13 (1987), 78–82.
78. Habets, W.J., Berden, J.H.M., Hoch, S.O., Van Venrooij, W.J., Further characterization and subcellular localization of Sm and Ul ribonucleoprotein antigens. Eur. J. Immunol. 15 (1985), 992–997.
79. Weiben, E.D., Rohleder, A.M., Nenninger, J.M., Pederson, T., cDNA cloning of a human autoimmune nuclear ribonucleoprotein antigen. Proc. Natl. Acad. Sci. U.S.A. 82 (1985), 7914–7918.
80. Mimori, T., Hinterberger, M., Pettersson, I., Steitz, J.A., Autoantibodies to the U2 small nuclear ribonucleoprotein in a patient with sclerodermapolymyositis overlap syndrome. J. Biol. Chem. 259 (1984), 560–565.
81. Habets, W., Holt, M., Bingmann, P., Lechrman, R., Van Venrooij, W.J., Autoantibodies to ribonucleoprotein particles containing U2 small nuclear RNA. EMBO J. 4 (1985), 1545–1550.
82. Verheijen, R., Kuippers, H., Vooijs, P., Van Venrooij, W., Ramaekers, F., Distribution of the 70 K Ul RNA-associated protein during interphase and mitosis. J. Cell Sci. 86 (1986), 173–190.
83. Maniatis, T., Reed, R., The role of small nuclear ribonucleoprotein particles in pre-mRNA splicing. Nature (London) 325 (1987), 673–678.
84. Clark, G., Reichlin, M., Tomasi, T.B., Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus. J. Immunol. 102 (1969), 117–124.
85. Alspaugh, M.A., Maddison, P., Arthritis Rheum., 22, 1979, 796.
86. Sontheimer, R.D., Thomas, J.R., Gillian, J.N., Subacute cutaneous lupus erythematosus subset. Arch. Dermatol. 115 (1979), 1409–1415.
87. Sontheimer, R.D., Maddison, P.J., Reichlin, M., Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann. Intern. Med. 97 (1982), 664–671.
88. Hendrick, J.P., Wolin, S.L., Rinke, J., Lerner, M.R., Steitz, J.A., Ro small cytoplasmic ribonucleoproteins are a subclass of La ribonucleoproteins: Further characterization of the Ro and La small ribonucleoproteins from uninfected mammalian cells. Mol. Cell. Biol. 1 (1981), 1138–1148.
89. Harmon, C.E., Deng, J.S., Peebles, C.L., Tan, E.M., The importance of tissue substrate in the SS-A/Ro antigen-antibody system. Arthritis Rheum. 27 (1984), 166–173.
90. Franco, H.L., Weston, W.L., Peebles, C., Forstot, S.L., Phanuphak, P., Autoantibodies directed against sicca syndrome antigens in the neonatal lupus syndrome. J. Am. Acad. Dermatol. 4 (1981), 67–72.
91. Provost, T.T., Neonatal lupus. Arch. Dermatol. 119 (1983), 619–622.
92. Agnello, V., Association of systemic lupus erythematosus and SLE-like syndromes with hereditary and acquired complement deficiency states. Arthritis Rheum., 21, 1978, 5146.
93. Meyer, O., Hauptmann, G., Tappeiner, G., Ochs, H.D., Genetic deficiency of C4, C2 or Clq and lupus syndromes. Association with anti-Ro (SS-A) antibodies. Clin. Exp. Immunol. 62 (1985), 678–684.
94. Reichlin, M., Harley, J.B., “Antibodies to Ro(SSA) and the heterogeneity of systemic lupus erythematosus.” J. Rheumatol. 14:Suppl. 13 (1987), 112–117.
95. Wolin, S.L., Steitz, J.A., The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNAs. Proc. Natl. Acad. Sci. U.S.A. 81 (1984), 1996–2000.
96. Tojo, T., Kaburaki, J., Hayakawa, M., Okamato, T., Tomii, M., Homma, M., “Precipitating antibody to a soluble nuclear antigen “Ki” with specificity for systemic lupus erythematosus.”. Ryumachi 21:Suppl. (1981), 129–137.
97. Mimori, T., Hardin, J.A., Steitz, J.A., Characterization of the DNA-binding protein Ku recognized by autoantibodies from patients with rheumatic disorders. J. Biol. Chem. 261 (1986), 2274–2278.
98. Schur, P.H., Moroz, L.A., Kunkel, H.G., Precipitating antibodies to ribosomes in the serum of patients with systemic lupus erythematosus. Immunochemistry, 4, 1967, 447.
99. Lamon, E.W., Bennett, J.C., Antibodies to ribosomal ribonucleic acid (rRNA) in patients with systemic lupus erythematosus (SLE). Immunology, 19, 1970, 439.
100. Bianchi, F.B., Rizzetto, M., Penfold, P., Swana, G.T., Doniach, D., Ultrastructural localization and characterization of ribosomal antibody detected by immunofluorescence in systemic lupus erythematosus. Clin. Exp. Immunol., 17, 1974, 629.
101. Koffler, D., Miller, T.E., Lahita, R.G., Studies on the specificity and clinical correlation of antiribosomal antibodies in systemic lupus erythematosus sera. Arthritis Rheum., 22, 1979, 463.
102. Miyachi, K., Tan, E.M., Antibodies reacting with ribosomal ribonucleoproteins in connective tissue disease. Arthritis Rheum. 22 (1979), 87–93.
103. Gordon, J., Towbin, H., Rosenthal, M., Antibodies directed against ribosomal protein determinants in the sera of patients with connective tissue disease. J. Rheum. 9 (1982), 247–252.
104. Vidales, F.J., Sanchez-Madrid, F., Ballesta, J.P.G., The acidic proteins of eukaryotic ribosomes. A comparative study. Biochim. Biophys. Acta 656 (1981), 28–35.
105. Stoffler, G., Wool, I.G., Lin, A., Rak, K.-H., The identification of the eukaryotic ribosomal proteins homologous with Escherichia coli proteins L7 and L12. Proc. Natl. Acad. Sci. U.S.A. 71 (1974), 4723–4726.
106. Howard, G.A., Lane Smith, R., Gordon, J., Chicken liver ribosomes: Characterization of cross-reaction and inhibition of some functions by antibodies prepared against E. coli ribosomal proteins L17 and L12. J. Mol. Biol. 106 (1976), 623–637.
107. Zinker, S., Warner, J.R., The ribosomal proteins of Saccharomyces cerebisiae. Phosphorylated and exchangeable proteins. J. Biol. Chem. 251 (1976), 1799–1807.
108. Wool, I.G., The structure and function of eukaryotic ribosomes. Annu. Rev. Biochem. 48 (1979), 719–754.
109. Sanchez-Madrid, F., Reyes, R., Condi, P., Ballesta, J.P.G., Acidic ribosomal proteins from eukaryotic cells. Effect on ribosomal functions. Eur. J. Biochem. 98 (1979), 409–416.
110. Elkon, K., Skelly, S., Parnassa, A., Moller, W., Danho, W., Weissback, H., Brot, N., Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus. Proc. Natl. Acad. Sci. U.S.A. 83 (1986), 7419–7423.
111. Bonfa, E., Golombek, S.J., Kaufman, L.D., Skelly, S., Weissback, H., Brot, N., Elkon, K.B., Association between lupus psychosis and anti-ribosomal P protein antibodies. N. Engl. J. Med. 317 (1987), 265–271.
112. Bravo, R., Celis, J.E., A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells. J. Cell Biol. 84 (1980), 795–803.
113. Ogata, K., Kurki, P., Celis, J.E., Nakamura, R.M., Tan, E.M., Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication. Exp. Cell Res. 168 (1987), 475–486.
114. Kurki, P., Vanderlaan, M., Dolbeare, F., Gray, J., Tan, E.M., Expression of the proliferating cell nuclear antigen during the cell cycle. Exp. Cell Res. 166 (1986), 209–219.
115. Kurki, P., Lotz, M., Ogata, K., Tan, E.M., Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes. J Immunol. 138 (1987), 4114–4120.
116. Matsumoto, K., Moriuchi, T., Koji, T., Nakane, P.K., Molecular cloning of cDNA coding for rat proliferating cell nuclear antigen (PCNA)/cyclin. EMBO J., 6, 1987, 637.
117. Almendral, J.M., Huebsch, D., Blundell, P.A., Macdonald-Bravo, H., Bravo, R., Cloning and sequence of the human nuclear protein cyclin: Homology with DNA-binding proteins. Proc. Natl. Acad. Sci. U.S.A. 84 (1987), 1575–1581.
118. Tan, C.-K., Castillo, C., So, A.G., Downey, K.M., An auxiliary protein for DNA polymerase δ from fetal calf thymus. J. Biol. Chem. 261 (1986), 12310–12316.
119. Mathews, M.B. (1988). “The proliferating cell nuclear antigen, PCNA, a cell-cycle regulated DNA replication factor.” CRC Crit. Rev. Biochem. (In press).
120. Tan, C.-K., Sullivan, K., Li, X., Tan, E.M., Downey, K.W., So, A.G., Autoantibody to the proliferating cell nuclear antigen neutralizes the activity of the auxiliary protein for DNA polymerase delta. Nucleic Acids Res. 15 (1987), 9299–9308.
121. Ogata, K., Ogata, Y., Takasaki, Y., Tan, E.M., Epitopes on proliferating cell nuclear antigen recognized by human lupus autoantibody and murine monoclonal antibody. J. Immunol. 139 (1987), 2942–2946.
122. Minota, S., Koyasu, S., Yahara, I., Winfield, J., Autoantibodies to the heat-shock protein hsp 90 in systemic lupus erythematosus. J. Clin. Invest. 81 (1988), 106–109.
123. Koyasu, S., Nishida, E., Kadowski, T., Matsuzaki, F., lida, K., Harada, F., Kasuga, M., Sakai, H., Yahara, I., Two mammalian heat-shock proteins, Hsp 90 and Hsp 100 are actin-binding proteins. Proc. Natl. Acad. Sci. U.S.A. 83 (1986), 8054–8058.
124. Winfield, J.B., Davis, J.S., Anti-DNA antibody in procainamideinduced lupus erythematosus. Arthritis Rheum. 17 (1974), 97–110.
125. Rubin, R.L., McNally, E.M., Nusinow, S.R., Robinson, C.A., Tan, E.M., IgG antibodies to the histone complex H2A-H2B characterize procainamideinduced lupus. Clin. Immunol. Immunopathol. 36 (1985), 49–59.
126. Rubin, R.L., “Autoimmune reactions induced by procainamide and hydralazine.”. Kammuller, M., Bloksma, M., Siemen, W., (eds.) “Autoimmunity and Toxicology. Immune Disregulation Induced by Drugs and Chemicals”, 1988, Elsevier, Amsterdam (in press).
127. Fritzler, M.J., Tan, E.M., Antibodies to histones in drug-induced and idiopathic lupus erythematosus. J. Clin. Invest. 62 (1978), 560–567.
128. Woosley, R.L., Drager, D.E., Reidenberg, M.M., Nies, A.S., Carr, K., Oates, J.A., Effect of acetylator phenotype ont he rate at which procainamide induces antinuclear antibodies and the lupus syndrome. N. Engl. J. Med. 298 (1987), 1157–1159.
129. Totoritis, M.C., Tan, E.M., McNally, E.M., Rubin, R.L., Association of anti-histone (H2A-H2B) complex antibody with symptomatic procainamideinduced lupus. N. Engl. J. Med. 318 (1988), 1431–1436.
130. Ziff, M., Genetics, hypersensitivity and the connective tissue diseases. Am. J. Med. 30 (1961), 1–7.
131. Kasukawa, R., Kasukawa, R., Sharp, G.C. Jr., (eds.) “Preliminary diagnostic criteria for classification of mixed connective tissue disease.”: “Mixed Connective Tissue Disease and Anti-Nuclear Antibodies”, 1987, Excerpta Medica, Amsterdam, 41–47.
132. Venables, P.J.W., Smith, P.R., Maini, R.N., Purification and characterization of Sjogren's syndrome A and B antigens. Clin. Exp. Immunol. 54 (1983), 731–740.
133. Ben-Chetrit, E., Chan, E.K.L., Sullivan, K.F., Tan, E.M., A 52 kD protein is a novel component of the SS-A/Ro antigenic particle. J. Exp. Med. 167 (1988), 1560–1571.
134. Madone, S.J., Wieben, E.D., Pederson, T., Eukaryotic small ribonucleoproteins. Anti-La human autoantibodies react with Ul RNAprotein complexes. J. Biol. Chem. 259 (1984), 1929–1935.
135. Wilusz, J., Kurilla, M.G., Keene, J.D., A host protein (La) binds to unique species of minus-sense leader RNA during replication of vesicular stomatitis virus. Proc. Natl. Acad. Sci. U.S.A. 80 (1983), 5827–5831.
136. Mathews, M.B., Francoeur, A.M., La antigen recognizes and binds to the 3'-oligouridylate tail of a small RNA. Mol. Cell Biol. 4 (1984), 1134–1139.
137. Stefano, J.E., Purified lupus antigen La recognizes an oligouridylate stretch common to the 3’ termini of RNA polymerase III transcripts. Cell 36 (1984), 145–152.
138. Francoeur, A.M., Chan, E.K.L., Garrels, J.I., Mathews, M.B., Characterization and purification of lupus antigen La, an RNA-binding protein. Mol. Cell Biol. 5 (1985), 581–590.
139. Linne, T., Philippson, L., Further characterization of the phosphate moiety of the adenovirus type 2 DNA-binding protein. Eur. J. Biochem. 103 (1980), 259–270.
140. Pizer, L.I., Deng, J.S., Stenberg, R.M., Tan, E.M., Characterization of a phosphoprotein associated with the SS-B/La nuclear antigen in adenovirusinfected and uninfected KB cells. Mol. Cell Biol. 3 (1983), 1235–1245.
141. Chan, E.K.L., Tan, E.M., Human autoantibody-reactive epitopes of SS-B/La are highly conserved in comparison with epitopes recognized by murine monoclonal antibodies. J. Exp. Med. 166 (1987), 1627–1640.
142. Nishikai, M., Reichlin, M., Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis: Characterization of the Jo-1 antibody system. Arthritis Rheum. 23 (1980), 881–888.
143. His-containing antigen is recognized by the polymyositis-specific antibody anti-Jo-1. Nucleic Acids Res. 11 (1983), 853–870.
144. Mathews, M.B., Bernstein, R.M., Myositis autoantibody inhibits histidyl-tRNA synthetase: A model for autoimmunity. Nature (London) 304 (1983), 177–179.
145. Yang, D.C.H., Dang, C.V., Arnett, F.C., Rat liver histidyl-tRNA synthetase. Purification and inhibition by the myositis-specific anti-Jo-1 autoantibody. Biochem. Biophys. Res. Commun. 120 (1984), 15–21.
146. Bernstein, R.M., Morgan, S., Chapman, H., Bunn, J., Mathews, M.B., Turner-Wamwick, M., Hughes, G.R., Anti-Jo-1 antibody: A marker for myositis with interstitial lung disease. Br. Med. J. 189 (1984), 151–152.
147. Mathews, M.B., Reichlin, M., Hughes, G.R., Bernstein, R.M., Antithreonyl-tRNA synthetase, a second myositis-related autoantibody. J. Exp. Med. 160 (1984), 420–434.
148. Bunn, C.C., Bernstein, R.M., Mathews, M.B., Autoantibodies against alanyl-tRNA synthetase and tRNA Ala coexist and are associated with myositis. J. Exp. Med. 163 (1986), 1281–1291.
149. Bunn, C.C., Mathews, M.B., Autoreactive epitope defined as the anticodon region of alanine transfer RNA. Science 238 (1987), 1116–1119.
150. Fahoum, S.K., Yang, D.C.H., Purification of mammalian histidyl-tRNA synthetase and its interaction with myositis-specific anti-Jo-1 antibodies. Biochemistry 26 (1987), 5871–5877.
151. Dang, C.V., Tan, E.M., Traugh, J.A., Myositis autoantibody reactivity and catalytic function of threonyl-tRNA synthetase. FASEB J. 2 (1988), 2376–2379.
152. Reichlin, M., Maddison, P.J., Targoff, I., Bunch, T., Arnett, F., Sharp, G., Treadwell, E., Tan, E.M., Antibodies to a nuclear/nucleolar antigen in patients with polymyositis overlap syndromes. J. Clin. Immunol. 4 (1984), 40–47.
153. Reimer, G., Scheer, U., Peters, J.M., Tan, E.M., Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes. J. Immunol. 137 (1986), 3802–3808.
154. Targoff, I.N., Reichlin, M., The association between Mi-2 antibodies and dermatomyositis. Arthritis Rheum. 28 (1985), 796–803.
155. Nakao, Y., Mukai, R., Kabashima, T., Ohshima, Y., Hamaguchi, H., Kashiwagi, H., Okada, N., A novel antibody which precipitates 7.5S RNA is isolated from a patient with autoimmune disease. Biochem. Biophys. Res. Commun. 109 (1982), 1332–1336.
156. Reeves, W.H., Nigam, S.K., Blobel, G., Human autoantibodies reactive with the signal recognition particle. Proc. Natl. Acad. Sci. U.S.A. 83 (1986), 9507–9511.
157. Okada, N., Mimori, T., Mukai, R., Kashiwagi, H., Hardin, J.A., Characterization of human autoantibodies that selectively precipitate the 7SL RNA component of the signal recognition particle. J. Immunol. 138 (1987), 3219–3223.
158. Tan, E.M., Rodman, G.P., Garcia, I., Moroi, Y., Fritzler, M., Peebles, C., Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome. Arthritis Rheum. 23 (1980), 617–625.
159. Jarzabek-Chorzelska, M., Balszczyk, M., Jablonska, S., Chorzelski, T., Kumar, V., Beutner, E.H., Scl-70 antibody—a specific maker of systemic sclerosis. Br. J. Dermatol. 115 (1986), 393–401.
160. Moroi, Y., Peebles, C., Fritzler, M.J., Steigerwald, J., Tan, E.M., Autoantibody to centromere (kinetochore) in scleroderma sera. Proc. Natl. Acad. Sci. U.S.A. 77 (1980), 1627–1631.
161. Fritzler, M.J., Kinsella, T.D., Garbutt, E., The CREST syndrome: A distinct serologic entity with anticentromere antibodies. Am. J. Med. 69 (1980), 520–526.
162. Brenner, S., Pepper, D., Berne, M.E., Tan, E.M., Brinkley, B.R., Kinetochore structure, duplication and distribution in mammalian cells: Analysis by human autoantibodies from scleroderma patients. J. Cell Biol. 91 (1981), 95–102.
163. Moroi, Y., Hartman, A.L., Nakane, P.K., Tan, E.M., Distribution of kinetochore (centromere) antigen in mammalian cell nuclei. J. Cell. Biol. 90 (1981), 254–259.
164. Cox, J.V., Schenk, E.A., Olmsted, J.B., Human anticentromere antibodies: Distribution, characterization of antigens and effect on microtubule organization. Cell 35 (1983), 331–339.
165. Guldner, H.H., Lakomek, H.J., Bautz, F.A., Human anticentromere sera recognize a 19.5 kD nonhistone chromosomal protein from HeLa cells. Clin. Exp. Immunol. 58 (1985), 13–20.
166. Earnshaw, W.C., Bordwell, B.J., Marino, C., Rothfield, N.F., Three human chromosomal autoantigens are recognized by sera from patients with anticentromere antibodies. J. Clin. Invest. 77 (1986), 426–430.
167. Earnshaw, W.C., Sullivan, K.F., Machlin, P.S., Cooke, C.A., Kaiser, D.A., Pollard, T.D., Rothfield, N.F., Cleveland, D.W., Molecular cloning of cDNA for CENP-B, the major human centromere autoantigen. J. Cell Biol. 104 (1987), 817–829.
168. Maricq, H.R., Harper, F.E., Khan, M.M., Tan, E.M., Leroy, E.C., Microvascular abnormalities as possible predictors of disease subsets in Raynaud phenomenon and early connective tissue disease. Clin. Exp. Rheumatol. 1 (1983), 195–205.
169. Ringertz, N.R., Ege, T., Carlsson, S.A., Kulonen, E., Pokarainen, Q.J. Jr., (eds.) “Nucleolus specific antigens in human fibroblast and hybrid cells studied with patient autoantibodies.”: “Biology of the Fibroblast”, 1973, Academic Press, New York, 189–194.
170. Hernandez-Verdun, D., Bouteille, M., Ege, T., Ringertz, N.R., Fine structure of the nucleoli in micronucleated cells. Exp. Cell Res. 124 (1979), 223–235.
171. Reimer, G., Rose, K.M., Scheer, U., Tan, E.M., Autoantibody to RNA polymerase I in scleroderma sera. J. Clin. Invest. 79 (1987), 65–72.
172. Reimer, G., Raska, I., Tan, E.M., Scheer, U., Human autoantibodies: Probes for nucleolus structure and function. Virchows Arch. B. 54 (1987), 131–143.
173. Scheer, U., Rose, K.M., Localization of RNA polymerase I in interphase cells and mitotic chromosomes by light and electron microscopic immunocytochemistry. Proc. Natl. Acad. Sci. U.S.A. 81 (1984), 1431–1435.
174. Reimer, G., Pollard, K.M., Penning, C.A., Ochs, R.L., Lischwe, M.A., Busch, H., Tan, E.M., Monoclonal autoantibody from NZB/NZW Fl mouse and some human scleroderma sera target a Mr 34,000 nucleolar protein of the U3-ribonucleoprotein particle. Arthritis Rheum. 30 (1987), 793–800.
175. Ochs, R.L., Lischwe, M.A., Spohn, W.H., Busch, H., Fibrillarin: A new protein of the nucleolus identified by autoimmune sera. Biol. Cell 54 (1985), 123–134.
176. Reddy, R., Tan, E.M., Henning, D., Nohga, K., Busch, H., Detection of nucleolar 7–2 ribonucleoprotein and a cytoplasmic 8–2 ribonucleoprotein with autoantibodies from patients with scleroderma. J. Biol. Chem. 258 (1983), 1383–1386.
177. Parker, K.A., Steitz, J.A., Structural analyses of the human U3 ribonucleoprotein particle reveal a conserved sequence available for base pairing with pre-rRNA. Mol. Cell. Biol. 7 (1987), 2899–2913.
178. G-dimethylarginine. J Biol. Chem. 260 (1985), 14304–14310.
179. Christensen, M.E., Moloo, J., Swischuk, J.L., Schelling, M.E., Characterization of the nucleolar protein, B-36, using monoclonal antibodies. Exp. Cell Res. 16 (1986), 77–93.
180. Vaughan, M.A., An autoimmune antibody from scleroderma patients recognize a component of the plant cell nucleolus. Histochem. J. 86 (1987), 533–535.
181. Reimer, G., Steen, V.D., Penning, C.A., Medsger, T.A., Tan, E.M., Correlates between autoantibodies to nucleolar antigens and clinical features in patients with systemic sclerosis (scleroderma). Arthritis Rheum. 31 (1988), 525–532.
182. Hashimoto, C., Steitz, J.A., Sequential association of nucleolar 7–2 RNA with two different autoantigens. J. Biol. Chem. 258 (1983), 1379–1382.
183. Reimer, G., Scheer, U., and Tan, E.M. (1988). “Immunolocalization of 7–2 ribonucleoprotein in the granular component of the nucleolus.” Exp. Cell Res. (In press).
184. Rodriguez-Sanchez, J., Gelpi, C., Juarez, C., Hardin, J.A., A new autoantibody in scleroderma that recognizes a 90-kDa component of the nucleolusorganizing region of chromatin. J. Immunol. 139 (1987), 2579–2584.
185. McKeon, F.D., Tuffanelli, D.L., Fukuyama, K., Kirschner, M.W., Autoimmune response directed against conserved determinants of nuclear envelope proteins in a patient with linear scleroderma. Proc. Natl. Acad. Sci. U.S.A. 80 (1983), 4374–4378.
186. Reeves, W.H., Chaudhary, N.L., Salerno, A., Blobel, G., Lamin B autoantibodies in sera of patients with systemic lupus erythematosus. J. Exp. Med. 165 (1987), 750–762.
187. Lassoued, K., Guilly, M.N., Danon, F., Andre, C., Chumeaux, D., Clauvel, J.-P., Brouet, J.C., Seligmann, M., Courvalin, J.-C., Antinuclear antibodies specific for lamins: Characterization and clinical significance. Ann. Intern. Med. 108 (1988), 829–833.
188. Wesierska-Gadek, J., Penner, E., Hitchman, E., Sauermann, G., Antibodies to nuclear lamins in autoimmune liver disease. Clin. Immunol. Immunopathol. 49 (1988), 107–115.
189. Gerace, L., Nuclear lamina and organization of nuclear architecture. Trends Biochem. Sci. 11 (1986), 443–446.
190. Franke, W.W., Nuclear lamins and cytoplasmic intermediate filament proteins: A growing multigene family. Cell 48 (1987), 3–4.
191. Tan, E.M., Autoantibodies to nuclear lamins. Ann. Intern. Med. 108 (1988), 897–898.
192. Ueda, K., Hayaishi, O., ADP-ribosylation. Annu. Rev. Biochem. 54 (1985), 73–100.
193. Yamanaka, H., Willis, E.H., Penning, C.A., Peebles, C.L., Tan, E.M., Carson, D.A., Human autoantibodies to poly-adenosine diphosphate-ribose) polymerase. J. Clin. Invest. 80 (1987), 900–904.
194. Cherney, B.W., McBride, O.W., Chen, D., Alkhateb, H., Bhatia, K., Hensley, P., Smulson, M.E., cDNA sequence, protein structure and chromosomal location of the human gene for poly(ADP-ribose) polymerase. Proc. Natl. Acad. Sci. U.S.A. 84 (1987), 8370–8374.
195. Yamanaka, H., Penning, C.A., Willis, E.H., and Carson, D.A. (1988). Human autoantibodies to poly(ADP-ribose) polymerase recognize cross-reactive epitopes associated with the catalytic site of the enzyme. Submitted.
196. Kole, R., Fresco, L.D., Keene, J.D., Cohen, P.L., Eisenberg, R.A., Andrews, P.G., Alu RNA-protein complexes formed in vitro react with a novel lupus autoantibody. J. Biol. Chem. 260 (1985), 11781–11786.
197. McCarty, G.A., Valencia, D.W., Fritzler, M.J., Antibody to the mitotic spindle apparatus: Immunologic characteristics and cytologic studies. J. Rheumatol. 11 (1984), 213–218.
198. Price, C.M., McCarty, G.A., Pettijohn, D.E., NuMA protein is a human autoantigen. Arthritis Rheum. 27 (1984), 774–779.
199. Szostecki, C., Krippner, H., Penner, E., Bautz, F.A., Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100). Clin. Exp. Immunol. 68 (1987), 108–116.
200. Brenner, S., Pepper, D.A., Berns, M.W., Brinkley, B., “Autoantibodies in human sera selectively bind to the centriole region in cultured cells”. J. Cell Biol., 87, 1980, 1826a.
201. Tuffanelli, D.L., McKeon, F., Kleinsmith, D.M., Burnham, T.K., Kirschner, M., Anticentromere and anticentriole antibodies in the scleroderma spectrum. Arch. Dermatol. 119 (1983), 560–566.
202. Osbom, T.G., Patel, N.J., Ross, S.C., Bauer, N.E., Autinuclear antibody staining only centrioles in a patient with scleroderma. N. Engl. J. Med. 307 (1982), 253–254.
203. Rodriquez, J.L., Gelpi, C., Thomson, T.M., Real, F.J., Fernandez, J., Anti-golgi complex antibodies in a patient with Sjogren's syndrome and lymphoma. Clin. Exp. Immunol. 49 (1982), 579–603.
204. Fritzler, M.J., Etherington, J., Sokoluk, C., Kinsella, T.D., Valencia, D.W., Antibodies from patients with autoimmune disease react with a cytoplasmic antigen in the Golgi apparatus. J. Immunol. 132 (1984), 2904–2908.
205. Senecal, J.L., Oliver, J.M., Rothfield, N., Anticytoskeletal autoantibodies in the connective tissue diseases. Arthritis Rheum. 28 (1985), 889–898.
206. Fritzler, M.J., Valencia, D.W., McCarty, G.A., Speckled pattern antinuclear antibodies resembling anticentromere antibodies. Arthritis Rheum. 27 (1984), 92–96.
207. Jeppesen, P., Nicol, L., Non-kinetochore directed autoantibodies in scleroderma/CREST. Identified of an activity recognizing a metaphase chromosome core non-histone protein. Mol. Biol. Med. 3 (1986), 369–384.
208. Wolin, S.L., Steitz, J.A., Genes for two small cytoplasmic Ro RNAs are adjacent and appear to be single-copy in the human genome. Cell 32 (1983), 735–744.
209. Chambers, J.C., Keene, J.D., Isolation and analysis of cDNA clones expressing human lupus La antigen. Proc. Natl. Acad. Sci. U.S.A. 82 (1985), 2115–2119.
210. Wieben, E.D., Rohleder, A.M., Nenninger, J.M., Pederson, T., cDNA cloning of a human autoimmune nuclear ribonucleoprotein antigen. Proc. Natl. Acad. Sci. U.S.A. 82 (1985), 7914–7918.
211. Habets, W.J., Sillekens, P.T.G., Hoet, M.H., Schalken, J.A., Roebroeck, A.J.M., Leunissen, J.A.M., van de Ven, W.J.M., Van Venrooij, W.J., Analysis of a cDNA clone expressing a human autoantigen: Full length sequence of the U2 small nuclear RNA-associated B” antigen. Proc. Natl. Acad. Sci. U.S.A. 84 (1987), 2421–2425.
212. Sillekens, P.T.G., Habets, W.J., Beijer, R.P., Van Venroouj, W.J., cDNA cloning of the human Ul snRNA-associated A protein: Extensive homology between U1 and U2 snRNP-specific proteins. EMBO J. 6 (1987), 3841–3848.
213. Theissen, H., Etzerodt, M., Reuter, R., Schneider, C., Lottspeich, F., Argos, P., Luhrmann, R., Philipson, L., Cloning of the human cDNA for the Ul RNA-associated 70 K protein. EMBO J. 5 (1986), 3209–3217.
214. gag antigen. Cell 51 (1987), 211–220.
215. Yamamoto, K., Miura, H., Moroi, Y., Yoshinoya, S., Goto, M., Nishioka, K., Miyamoto, T., Isolation and characterization of a complementary DNA expressing human Ul small nuclear ribonucleoprotein C polypeptide. J. Immunol. 140 (1988), 311–317.
216. Shores, T.W., Eisenberg, R.A., Cohen, R.L., Role of the Sm antigen in the generation of anti-Sm autoantibodies in the SLE-prone MRL mouse. J. Immunol. 136 (1986), 3662–3667.
217. Rosario, M.O., Fox, O.F., Koren, E., Harley, J.B., Anti-Ro (SS-A) antibodies from Ro (SS-A)-immunized mice. Arthritis Rheum. 31 (1988), 227–237.
218. Muller, M.T., Pfund, W.P., Mehta, V.B., Trask, D.F., Eukaryotic type I topisomerase is enriched in the nucleolus and catalytically active in ribosomal DNA. EMBO J. 4 (1985), 1237–1243.
219. Matsui, S., Sandberg, A.A., Intranuclear compartmentalization of DNA-dependent RNA polymerases: Association of RNA polymerase I with nucleolar organizing chromosomes. Chromosoma 92 (1985), 1–6.
220. Tan, E.M., Lerner, R.A., An immunologic approach to the fate of nuclear and nucleolar macromolecules during the cell cycle. J. Mol. Biol. 68 (1972), 107–114.
221. Jonsson, J., Norberg, R., Some functional properties of the RNP nucleoplasmic antigen. Scand. J. Immunol. 12 (1980), 119–127.
222. Reuter, R., Appel, B., Rinke, J., Luhrmann, R., Localization and structure of snRNPs during mitosis. Immunofluorescent and biochemical studies. Exp. Cell Res. 159 (1985), 63–79.
223. Spector, D.L., Smith, H.C., Redistribution of U-snRNPs during mitosis. Exp. Cell Res. 163 (1986), 87–94.
224. Verheijen, R., Kuypers, H., Vooijs, P., van Venroouj, W., Ramaekers, F., Distribution of the 70K Ul RNA-associated protein during interphase and mitosis. J. Cell Sci. 86 (1986), 173–190.
225. Ringertz, N., Hadlaczky, G., Hallman, H., Nyman, U., Pettersson, I., Sharp, G.C., Computer analysis of the distribution of nuclear antigens: Studies on the spatial and functional organization of the interphase nucleus. J. Cell Sci. Suppl. 4 (1986), 11–28.
226. Frendeway, D., Keller, W., Stepwise assembly of a pre-mRNA splicing complex requires U-snRNPs and specific intron sequences. Cell 42 (1985), 355–367.
227. Chabot, B., Steitz, J.A., Multiple interactions between the splicing substrate and small nuclear ribonucleoproteins in spliceosomes. Mol. Cell. Biol. 7 (1987), 281–293.
228. Zillman, M., Rose, S.D., Berget, S., Ul small nuclear ribonucleoproteins are required early during spliceosome assembly. Mol. Cell. Biol. 7 (1987), 2877–2883.
229. Bringmann, P., Rinke, J., Appel, B., Reuter, R., Luhrmann, R., Purification of snRNPs Ul, U2, U4, U5 and U6 with 2,2,7-trimethylguanosinespecific antibody and definition of their constituent proteins reacting with anti-Sm and anti-(Ul)RNP antisera. EMBO J. 2 (1983), 1129–1135.
230. Reuter, R., Luhrmann, R., Immunization of mice with purified Ul small nuclear ribonucleoprotein (RNP) induces a pattern of antibody specificities characteristic of the anti-Sm and anti-RNP autoimmune response of patients with lupus erythematosus, as measured by monoclonal antibodies. Proc. Natl. Acad. Sci. U.S.A. 83 (1986), 8689–8693.
231. Hadjiolov, A.A., “The nucleolus and ribosome biogenesis.”: “Cell Biology Monographs”, 1985, Springer-Verlag, New York.
232. Tainer, J.A., Gedzoff, E.D., Paterson, Y., Olson, A.J., Lerner, R.A., The atomic mobility component of protein antigenicity. Annu. Rev. Immunol. 3 (1985), 501–535.